Augusto Miravalle

1.3k total citations
28 papers, 629 citations indexed

About

Augusto Miravalle is a scholar working on Pathology and Forensic Medicine, Oncology and Infectious Diseases. According to data from OpenAlex, Augusto Miravalle has authored 28 papers receiving a total of 629 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pathology and Forensic Medicine, 8 papers in Oncology and 7 papers in Infectious Diseases. Recurrent topics in Augusto Miravalle's work include Multiple Sclerosis Research Studies (15 papers), Polyomavirus and related diseases (8 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Augusto Miravalle is often cited by papers focused on Multiple Sclerosis Research Studies (15 papers), Polyomavirus and related diseases (8 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Augusto Miravalle collaborates with scholars based in United States, Switzerland and Italy. Augusto Miravalle's co-authors include Rikke Beck Jensen, R. Philip Kinkel, John R. Corboy, Timothy Vollmer, Justin M. Honce, Danielle E. Harlow, Timothy R. Vollmer, Mrinalini Kala, Teri Schreiner and Bette K. Kleinschmidt‐DeMasters and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Journal of Neuropathology & Experimental Neurology.

In The Last Decade

Augusto Miravalle

25 papers receiving 608 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Augusto Miravalle United States 10 412 208 155 132 88 28 629
Annette Wundes United States 15 547 1.3× 265 1.3× 157 1.0× 161 1.2× 97 1.1× 35 813
Nolan Campbell United States 10 503 1.2× 363 1.7× 137 0.9× 109 0.8× 48 0.5× 35 618
Jai Perumal United States 14 385 0.9× 123 0.6× 184 1.2× 70 0.5× 70 0.8× 31 510
Ryan Ramanujam Sweden 14 472 1.1× 141 0.7× 185 1.2× 180 1.4× 133 1.5× 27 804
Jasem Al–Hashel Kuwait 20 587 1.4× 122 0.6× 214 1.4× 132 1.0× 83 0.9× 67 872
Cinzia Cordioli Italy 16 591 1.4× 206 1.0× 338 2.2× 145 1.1× 88 1.0× 29 837
Alexander Winkelmann Germany 15 585 1.4× 156 0.8× 239 1.5× 164 1.2× 137 1.6× 43 828
Claes Martin Sweden 12 260 0.6× 303 1.5× 100 0.6× 251 1.9× 119 1.4× 15 888
R. Philip Kinkel United States 11 529 1.3× 355 1.7× 257 1.7× 155 1.2× 76 0.9× 15 850
Christina Caon United States 20 783 1.9× 220 1.1× 381 2.5× 117 0.9× 122 1.4× 36 1.0k

Countries citing papers authored by Augusto Miravalle

Since Specialization
Citations

This map shows the geographic impact of Augusto Miravalle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Augusto Miravalle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Augusto Miravalle more than expected).

Fields of papers citing papers by Augusto Miravalle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Augusto Miravalle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Augusto Miravalle. The network helps show where Augusto Miravalle may publish in the future.

Co-authorship network of co-authors of Augusto Miravalle

This figure shows the co-authorship network connecting the top 25 collaborators of Augusto Miravalle. A scholar is included among the top collaborators of Augusto Miravalle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Augusto Miravalle. Augusto Miravalle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Dave, Rahul, et al.. (2024). COVID-19 Vaccination Response in Patients with Multiple Sclerosis Treated with Ofatumumab in the United States: A Medical Record Review. Neurology and Therapy. 13(6). 1737–1745. 1 indexed citations
4.
Miravalle, Augusto, Joshua Katz, Derrick Robertson, et al.. (2021). CLICK-MS and MASTER-2 Phase IV Trial Design: Cladribine Tablets in Suboptimally Controlled Relapsing Multiple Sclerosis. Neurodegenerative Disease Management. 11(2). 99–111. 6 indexed citations
5.
Swanson, Clayton W., et al.. (2021). Non-invasive brain stimulation to assess neurophysiologic underpinnings of lower limb motor impairment in multiple sclerosis. Journal of Neuroscience Methods. 356. 109143–109143. 6 indexed citations
6.
Álvarez, Enrique, Kavita Nair, Stefan Sillau, et al.. (2021). Brain atrophy rates in patients with multiple sclerosis on long term natalizumab resembles healthy controls. Multiple Sclerosis and Related Disorders. 55. 103170–103170. 10 indexed citations
7.
Rempe, Torge, et al.. (2020). Anti-JCV antibody index does not change during ocrelizumab-treatment. Multiple Sclerosis Journal - Experimental Translational and Clinical. 6(3). 2455380478–2455380478. 4 indexed citations
8.
Prosperini, Luca, et al.. (2019). Post-natalizumab disease reactivation in multiple sclerosis: systematic review and meta-analysis. Therapeutic Advances in Neurological Disorders. 12. 1278059377–1278059377. 64 indexed citations
9.
Tran, Vincent, et al.. (2019). The Effect of Ocrelizumab Therapy on Immunoglobulin Levels in Patients with Multiple Sclerosis (P4.2-042). Neurology. 92(15_supplement). 2 indexed citations
10.
11.
Harlow, Danielle E., Justin M. Honce, & Augusto Miravalle. (2015). Remyelination Therapy in Multiple Sclerosis. Frontiers in Neurology. 6. 257–257. 63 indexed citations
12.
Liewluck, Teerin & Augusto Miravalle. (2015). Immune-Mediated Neurological Disorders. Current Neurology and Neuroscience Reports. 15(9). 61–61. 3 indexed citations
13.
Miravalle, Augusto & Teri Schreiner. (2013). Neurologic complications of vaccinations. Handbook of clinical neurology. 121. 1549–1557. 7 indexed citations
14.
Campbell, Jonathan D., Vahram Ghushchyan, R. Brett McQueen, et al.. (2013). Burden of multiple sclerosis on direct, indirect costs and quality of life: National US estimates. Multiple Sclerosis and Related Disorders. 3(2). 227–236. 102 indexed citations
15.
Kleinschmidt‐DeMasters, Bette K., Augusto Miravalle, Jeffrey Schowinsky, John R. Corboy, & Timothy R. Vollmer. (2012). Update on PML and PML-IRIS Occurring in Multiple Sclerosis Patients Treated With Natalizumab. Journal of Neuropathology & Experimental Neurology. 71(7). 604–617. 85 indexed citations
16.
Kala, Mrinalini, Augusto Miravalle, & Timothy Vollmer. (2011). Recent insights into the mechanism of action of glatiramer acetate. Journal of Neuroimmunology. 235(1-2). 9–17. 54 indexed citations
17.
Miravalle, Augusto, José Biller, Eugene R. Schnitzler, & Andrew Bonwit. (2010). Neurological complications following vaccinations. Neurological Research. 32(3). 285–292. 20 indexed citations
18.
Miravalle, Augusto, Rikke Beck Jensen, & R. Philip Kinkel. (2010). Immune Reconstitution Inflammatory Syndrome in Patients With Multiple Sclerosis Following Cessation of Natalizumab Therapy. Archives of Neurology. 68(2). 186–91. 130 indexed citations
19.
Miravalle, Augusto, et al.. (2009). Acute disseminated encephalomyelitis: yellow fever vaccination. Arquivos de Neuro-Psiquiatria. 67(3a). 710–711. 6 indexed citations
20.
Miravalle, Augusto & Karen L. Roos. (2003). Encephalitis Complicating Smallpox Vaccination. Archives of Neurology. 60(7). 925–925. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026